Research Article
Serum Adiponectin Level as a Predictor of Subclinical Cushing’s Syndrome in Patients with Adrenal Incidentaloma
Table 1
Demographic, clinical, and metabolic characteristics of the adrenal incidentaloma patients and control subjects.
| | | Patients with AI
() | Control subjects
() | | | | (%) | (%) |
| | Gender | | | | | Female | 24 (60.0) | 22 (73.3) | 0.245 | | Male | 16 (40.0) | 8 (26.7) |
| | | Median () | Median () | |
| | Age, years | 60 (55.5–65.5) | 32 (24–44) | <0.001 | | Body mass index, kg/m2 | 29.1 (25.8–31.7) | 25.8 (22.8–28.3) | 0.004 | | Waist circumference, cm | 97 (90.5–104) | 85 (83–90) | <0.001 | | Waist-to-hip ratio | 0.90 (0.85–0.94) | 0.93 (0.92–0.95) | 0.049 | | Body fat percentage, % | 33.9 (24.6–41.9) | 29.1 (26.0–33.0) | 0.097 | | Fat-free mass, kg | 48.6 (44.9–55.9) | 44.8 (41.1–56.8) | 0.151 | | FBG, mg/dL | 93.5 (88–110) | 91 (88–97) | 0.147 | | Insulin, μIU/mL | 8.8 (5.6–11.2) | 6.6 (4.8–8.1) | 0.055 | | HOMA-IR | 1.94 (1.38–2.47) | 1.50 (1.20–1.98) | 0.079 | | Total cholesterol, mg/dL | 219.6 (187.4–249.8) | 173.2 (158.4–187.6) | <0.001 | | LDL-C, mg/dL | 132.0 (101.0–156.0) | 106.5 (94.0–120.0) | 0.006 | | HDL-C, mg/dL | 52.0 (42.0–67.0) | 46.0 (38.0–52.0) | 0.044 | | Triglycerides, mg/dL | 133.0 (102.0–189.0) | 83.5 (66.0–118.0) | <0.001 | | Adiponectin, ng/mL | 15.6 (11.7–48.3) | 39.3 (25.9–44.1) | 0.034 |
|
|
AI, adrenal incidentaloma; FBG, fasting blood glucose; HOMA-IR, homeostasis model assessment of insulin resistance; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol.
|
